CIK 0000010795 · Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 220760120
- Phone
- 2018476800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Muhsin Bilal EVP & President Connected Care | Grant or award | +14,342 | 43,294 | ||
| 2026-06-26 | Feld Michael EVP, Chief Revenue Officer | Sale 10b5-1 | −75 | $152.80 | $11K | 21,009 |
| 2026-06-24 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale 10b5-1 | −1,100 | $145.66 | $160K | 13,172 |
| 2026-06-10 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale 10b5-1 | −1,100 | $151.48 | $167K | 14,272 |
| 2026-06-01 | Polen Thomas E Jr Chairman, CEO and President | Option exercise 10b5-1 | +20,209 | $126.16 | $2.5M | 125,680 |
| 2026-06-01 | Polen Thomas E Jr Chairman, CEO and President | Returned to the company 10b5-1 | −17,445 | $146.15 | $2.5M | 108,235 |
| 2026-06-01 | Polen Thomas E Jr Chairman, CEO and President | Sale 10b5-1 | −2,764 | $146.35 | $405K | 110,163 |
| 2026-06-01 | Polen Thomas E Jr Chairman, CEO and President | Option exercise · Stock Appreciation Rights 10b5-1 | −20,209 | 0 | ||
| 2026-06-01 | Menziuso Peter EVP and President, BDI | Grant or award | +14,258 | 14,258 | ||
| 2026-05-26 | Feld Michael EVP, Chief Revenue Officer | Sale 10b5-1 | −75 | $147.35 | $11K | 21,084 |
| 2026-05-08 | Huffines Robert Luther Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +210 | $149.04 | $31K | 404 |
| 2026-05-08 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +105 | $149.04 | $16K | 3,699 |
| 2026-05-07 | Roque Vitor EVP & Chief Financial Officer | Grant or award | +1,721 | 8,231 | ||
| 2026-04-27 | Feld Michael EVP, Chief Revenue Officer | Sale 10b5-1 | −74 | $151.94 | $11K | 21,159 |
| 2026-04-06 | Neal Shana Carol EVP and Chief People Officer | Shares withheld for taxes | −1,146 | 23,966 | ||
| 2026-03-26 | Feld Michael EVP, Chief Revenue Officer | Sale 10b5-1 | −75 | $156.83 | $12K | 21,233 |
| 2026-03-16 | Minnix Lanesha EVP and General Counsel | Grant or award | +7,492 | 7,492 | ||
| 2026-03-02 | Roque Vitor Interim CFO | Grant or award | +931 | 6,510 | ||
| 2026-03-02 | Spikner Pamela L. SVP Controller & CAO | Grant or award | +931 | 3,323 | ||
| 2026-02-26 | Feld Michael EVP, Chief Revenue Officer | Sale 10b5-1 | −75 | $181.84 | $14K | 21,308 |
Page 2 of 7 · 135 trades